MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ImmuCell Company Profile (NASDAQ:ICCC)

Consensus Ratings for ImmuCell (NASDAQ:ICCC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ImmuCell (NASDAQ:ICCC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for ImmuCell (NASDAQ:ICCC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/11/2016Q1$0.11$2.99 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q315$0.09$2.21 million$2.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2015Q414$0.04$1.56 million$2.21 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.10)$1.37 million$1.54 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413($0.05)$1.42 million$1.56 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313$0.02$1.08 million$1.24 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.02)$1.00 million$1.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for ImmuCell (NASDAQ:ICCC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for ImmuCell (NASDAQ:ICCC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for ImmuCell (NASDAQ:ICCC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/21/2016David Scott TomscheDirectorBuy955$6.67$6,369.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2016David CunninghamDirectorBuy1,904$5.25$9,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Jonathan E. RothschildDirectorBuy3,000$6.63$19,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015David Scott TomscheDirectorBuy1,000$6.73$6,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Jonathan E. RothschildDirectorBuy6,100$7.37$44,957.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015David Scott TomscheDirectorBuy1,500$7.27$10,905.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Jonathan E RothschildDirectorBuy2,100$4.82$10,122.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Jonathan E RothschildDirectorBuy3,000$4.55$13,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Jonathan E RothschildDirectorBuy5,901$4.57$26,967.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014David CunninghamDirectorBuy1,500$3.91$5,865.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013Jonathan E RothschildDirectorBuy1,500$3.98$5,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013David CunninghamDirectorBuy4,000$3.68$14,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for ImmuCell (NASDAQ:ICCC)
DateHeadline
06/16/16 02:35 PMIMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements an -
06/15/16 03:47 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/23/16 09:10 AMIMMUCELL CORP /DE/ Files SEC form 8-K, Changes in Registrant's Certifying Accountant -
05/17/16 01:58 PMImmuCell Corp. :ICCC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/11/16 04:07 PM5-11-2016 “ImmuCell to Announce First Quarter 2016 Financial Results: - [at noodls] - 67f4cca2-45d5-4cfb-970b-5e9dcf3b9aaf.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell Announces First Quarter 2016 Financial Results Contact: Michael F. Brigham, President and CEO ImmuCell Corporation (207) ...
05/11/16 03:33 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi -
05/11/16 03:16 PMImmuCell Announces First Quarter 2016 Financial Results - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial ...
05/11/16 03:10 PMIMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly Report -
05/11/16 06:07 AMQ1 2016 ImmuCell Corp Earnings Release - After Market Close -
05/04/16 04:11 PM5-4-2016 “ImmuCell to Announce First Quarter 2016 Financial Results” - [at noodls] - 84222b57-0d47-404a-aa52-af8d75228d47.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell to Announce First Quarter 2016 Financial Results Conference Call Scheduled for Wednesday, May 11, 2016 at 4:30 PM EST Contact: ...
05/04/16 12:14 PMImmuCell to Announce First Quarter 2016 Financial Results - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, will report first ...
04/05/16 10:02 AM4-4-2016 “Immucell Appoints Elizabeth Williams Vice President of Manufacturing Operations - [at noodls] - be602b80-751b-4cc8-9a44-e19ae947019e.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations Contact: Michael F. Brigham, President and CEO ImmuCell ...
04/04/16 04:40 PMImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the ...
03/31/16 04:07 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balanc -
03/25/16 08:17 AMIMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report -
03/07/16 02:56 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibi -
02/16/16 12:03 PMImmuCell Corp. Earnings Analysis: 2015 By the Numbers -
02/10/16 03:05 PMImmuCell Announces Full Year 2015 Financial Results - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial ...
02/10/16 06:07 AMQ4 2015 ImmuCell Corp Earnings Release - After Market Close -
02/04/16 07:00 AMImmuCell to Announce 2015 Financial Results - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, will report financial ...
02/03/16 09:47 AMIMMUCELL CORP /DE/ Files SEC form 8-K, Other Events -
02/03/16 09:45 AMImmuCell Corporation Announces Closing of $5.9 Million Public Offering of Common Stock - [Marketwired] - ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the closing ...
01/29/16 04:32 PM1-28-2016 “ImmuCell Corporation Announces Proposed Public Offering” - [at noodls] - Exhibit 99.1 FOR IMMEDIATE RELEASE: ImmuCellCorporation Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results Contact: Michael F. Brigham, President and CEO ImmuCellCorporation ...
01/29/16 04:02 PM1-29-2016 “1ImmuCell Corporation Announces Pricing of $5.9 million Public Offering of Common Shares” - [at noodls] - 549d3a1a-6429-4f62-96ef-de29ad405514.pdf ImmuCell Exhibit 99.1 FOR IMMEDIATE RELEASE: ImmuCell Corporation Announces Pricing of $5.9 million Public Offering of Common Shares Contact: Michael F. Brigham, ...
01/29/16 02:25 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia -
01/29/16 01:42 PMMid-Day ETF Update: ETFs, Stocks Hold on to Gains as BOJ Rate Cut Eclipses Mixed Economic Data - Overstock.com (OSTK) rose 11.3% after the company said Merrill Lynch Professional Clearing Corporation has settled Overstock.com's claims in the long-standing market manipulation case by paying $20 million to Overstock.com and its co-plaintiffs.
01/29/16 06:31 AM7:31 am ImmuCell Corporation prices ~1.1 mln common stock offering at $5.25/share for net proceeds of ~$5.3 mln -
01/29/16 06:30 AMImmuCell Corporation Announces Pricing of $5.9 Million Public Offering of Common Shares - [Marketwired] - ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the pricing ...
01/28/16 04:52 PMImmuCell Corporation Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results - [Marketwired] - ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced a proposed......
01/07/16 02:51 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement -
01/06/16 01:45 PM1-6-2016 “ImmuCell Acquires Certain Assets from Minnesota Firm” - [at noodls] - 01c3d7c4-5d09-4743-a316-f7fbe0b92a36.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell Acquires Certain Assets from Minnesota Firm Contact: Michael F. Brigham, President and CEO ImmuCell Corporation (207) 878-2770 ...
01/06/16 07:00 AMImmuCell Acquires Certain Assets From Minnesota Firm - [Marketwired] - ImmuCell Corporation , a rapidly growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced ...
12/22/15 09:34 AM12-22-2015 “ImmuCell Enters into New Contract with Norbrook” - [at noodls] - b4aff101-61b0-4787-b302-9b8c377c20ab.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell Enters into New Contract with Norbrook Contact: Michael F. Brigham, President and CEO ImmuCell Corporation (207) 878-2770 ...
12/22/15 07:00 AMImmuCell Enters Into New Contract With Norbrook - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced ...
12/08/15 12:18 PMIMMUCELL CORP /DE/ Financials -
12/08/15 10:40 AMImmuCell Corp. Earnings Analysis: Q3, 2015 By the Numbers -
11/12/15 03:08 PMIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition -
11/12/15 03:05 PMImmuCell Announces Results for Third Quarter of 2015 - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced ...
11/12/15 06:07 AMQ3 2015 ImmuCell Corp Earnings Release - After Market Close -
11/10/15 02:46 PM11-5-2015 “ImmuCell to Announce Third Quarter 2015 Financial Results” - [at noodls] - 6bc0b971-bbb6-44b0-aade-21db8c59004f.pdf ImmuCell FOR IMMEDIATE RELEASE: ImmuCell to Announce Third Quarter 2015 Financial Results Conference Call Scheduled for Thursday, November 12, 2015 at 4:30 PM EST ...
11/05/15 07:00 AMImmuCell to Announce Third Quarter 2015 Financial Results - [Marketwired] - ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, will report third ...
About ImmuCell

ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing a new product that addresses mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. The Company's Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. The Company also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. The Company's product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICCC
  • CUSIP:
Key Metrics:
  • Previous Close: $7.18
  • 50 Day Moving Average: $6.75
  • 200 Day Moving Average: $6.79
  • P/E Ratio: 20.75
  • P/E Growth: 0.00
  • Market Cap: $30.00M
  • Current Quarter EPS Consensus Estimate: $nan EPS
Additional Links:
ImmuCell (NASDAQ:ICCC) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha